Literature DB >> 18389927

Acute and long-term adverse effects of antipsychotics.

Christoph U Correll1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18389927     DOI： 10.1017/s1092852900015959

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  9 in total

1.  [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro].

Authors:  M Lambert; C Correll
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

Review 2.  The interface of physical and mental health.

Authors:  Anne M Doherty; Fiona Gaughran
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-22       Impact factor: 4.328

3.  Psychotropic Drugs Prescription and Use among Children with Mental Disorders at a Tertiary Hospital in Vietnam.

Authors:  Nguyen Thi Phuong Lan; Ngo Thi Tam; Nguyen Xuan Bach; Le Cong Thien
Journal:  Hosp Pharm       Date:  2021-07-14

Review 4.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

5.  Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro.

Authors:  Alberto Canfrán-Duque; María E Casado; Oscar Pastor; Jana Sánchez-Wandelmer; Gema de la Peña; Milagros Lerma; Paloma Mariscal; Franz Bracher; Miguel A Lasunción; Rebeca Busto
Journal:  J Lipid Res       Date:  2012-11-21       Impact factor: 5.922

6.  The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.

Authors:  Olukayode Abayomi; Davide Amato; Candace Bailey; Byron Bitanihirwe; Lynneice Bowen; Shimon Burshtein; Alexis Cullen; Montserrat Fusté; Ana P Herrmann; Babak Khodaie; Sanja Kilian; Qortni A Lang; Elizabeth E Manning; Raffael Massuda; Milawaty Nurjono; Sarosh Sadiq; Teresa Sanchez-Gutierrez; Tamara Sheinbaum; Venkataram Shivakumar; Nicholas Simon; Anneliese Spiteri-Staines; Suttajit Sirijit; Nanna Gilliam Toftdahl; Sunali Wadehra; Yi Wang; Rebekah Wigton; Susan Wright; Sergey Yagoda; Yuliya Zaytseva; Anne O'Shea; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2014-10-11       Impact factor: 4.939

7.  Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.

Authors:  Robert O Cotes; David R Goldsmith; Sarah L Kopelovich; Cathy A Lally; Benjamin G Druss
Journal:  Community Ment Health J       Date:  2017-11-10

8.  Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation.

Authors:  Carole Deyts; Beatriz Galan-Rodriguez; Elodie Martin; Nicolas Bouveyron; Emmanuel Roze; Delphine Charvin; Jocelyne Caboche; Sandrine Bétuing
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

Review 9.  Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Authors:  Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho
Journal:  Ther Clin Risk Manag       Date:  2017-06-29       Impact factor: 2.423
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.